Insulin Pump Market Size to Reach USD 14.99 Billion by 2032 at 15.50% CAGR – Report by Market Research Future (MRFR)

Insulin Pumps Market Trends and Insights By Type (Smart Insulin Pumps, Traditional Insulin Pumps, and Disposable Insulin Pumps), By Accessories (Insulin Reservoirs, Infusion Sets and Infusion Set Insertion Devices), By Application (Type I Diabetes and Type II Diabetes), By End User (Hospitals and Clinics, Home Care, and Laboratories), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Competitive Market Growth, Size, Share and Forecast to 2032


New York, USA, June 22, 2023 (GLOBE NEWSWIRE) -- Insulin Pump Market Overview

According to a Comprehensive Research Report by Market Research Future (MRFR), “Insulin Pumps Market Information By Type, Accessories, Application, End User, And Region - Forecast till 2032", the market  is projected to grow from USD 4.73 Billion in 2023 to USD 14.99 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 15.50% during the forecast period (2023 - 2032).

Market Scope

Insulin pumps are compact, computerized devices programmed to administer a diabetic patient's prescribed amounts of insulin. In response to the increasing demand for handheld insulin dispensers among the diabetic population, the demand for these pumps has expanded recently. The rising incidence of diabetes, particularly type 1 diabetes, is a significant factor driving the market's expansion. In addition, leading manufacturers of medical devices have developed advanced pumps operated by smart technologies like artificially intelligent and machine learning, which has also emerged as a crucial growth factor for the market. An insulin pump makes it possible to administer insulin manually or automatically. When necessary, for instance, before a meal, these pumps may deliver an additional variety of amounts of insulin and a particular collection of insulin doses. Individuals can connect these gadgets to their smartphones to measure blood glucose readings. The development and introduction of AI-enabled pumps and additional automated drug delivery systems for type 2 diabetes can be spearheaded by medical device companies, which can also benefit from these trends.

Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/1637

The effects of nourishment and physical activity on blood sugar are among the many daily challenges people with diabetes must overcome. However, there is a growing need for novel therapies for managing the symptoms of the disease due to the rising prevalence of diabetes worldwide and the rising rates of diagnosis and treatment of the condition. These pumps are being adopted worldwide due to their advantages over multiple injections per day (MDIs), insulin pen systems, and other devices. Additionally, there is a demand for new management strategies due to the rising rates of type 2 diabetes diagnosis and treatment. Additionally, patients with type 2 diabetes becoming more dependent on insulin and switching from MDI to painless & alternative treatments have increased sales of these pumps. Intelligent technologies, like AI, have quickly gotten a foothold in the healthcare IT industry and are now steadily progressing in the management of diabetes.

Report Scope:

Report AttributeDetails
Market Size in 2032USD 14.99 Billion
CAGR15.50%
Base Year2022
Forecast Period2023-2032
Historical Data2021
Forecast UnitsValue (USD Billion)
Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments CoveredType, Accessories, Application, and End-User
Geographies CoveredNorth America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market DriversRising population of diabetic patients is driving the market growth
Increasing demand for technologically sophisticated pumps

Insulin Pump Market Competitive Landscape:

  • Abbott Laboratories
  • Braun Melsungen AG
  • Medtronics
  • Insulet Corporation
  • Dickinson and Company
  • Hoffmann-La Roche AG
  • Becton
  • Sanofi

Insulin Pumps Market Trends:

Market Drivers:

Unlike multiple daily injections (MDIs), insulin pumps have advantages, including better sugar tracking and continuous insulin flow. Major players are also releasing technologically cutting-edge products to support the market's expansion. The market players are encouraged to concentrate on the R&D of sophisticated goods and launch novel offerings considering the growing use of these pumps among people with diabetes in developing nations. The rising geriatric population, rising diabetes incidence, and rising obesity prevalence are primarily to blame for the market's expansion. Additionally, businesses are creating next-generation insulin pumps with cutting-edge technology to offer greater adherence and compatibility with IT devices, helping the market expand.

Technology advancements like home infusion therapy and artificial pancreas are also anticipated to generate sizable growth opportunities soon. Additionally, growing public awareness of insulin pumps as well as their use, has fueled market expansion in nations that are developing as well as developed. Numerous clinical trials conducted with these research and development initiatives have demonstrated sustained enhancement of glycemic management among patients with type 2 diabetes receiving pump therapy instead of those receiving MDI therapy. One of the drivers of the market's expansion is the rise in diabetes cases brought on by aging, obesity, and unhealthy lifestyle choices. Diabetes is primarily brought on by obesity, which also contributes to the rise in ophthalmic disorders linked to diabetes.

Restraints

The market expansion for insulin pumps is anticipated to be hampered during the assessment period by the rise in insulin costs coupled with unfavorable insurance policies. For major players, getting FDA approval is a significant barrier.

Browse In-depth Market Research Report (104 Pages) on Insulin Pumps: https://www.marketresearchfuture.com/reports/insulin-pump-market-1637

COVID 19 Analysis

The COVID-19 pandemic slowed insulin pump market expansion. Delays in diabetes diagnosis and treatment and patients' purchases of these pumps during this time were contributing factors. The COVID-19 pandemic had a favorable effect on the market for insulin pumps. Over 100 million infections and over 2 million fatalities have been caused by the COVID-19-causing SARS-CoV-2. Poor outcomes in COVID-19 patients, including a higher risk of fatal illness or severe illness, are associated with diabetes and uncontrolled hyperglycemia. Patients with type-1 diabetes are more affected by COVID-19. People Additionally, during the COVID-19 pandemic, restrictions put in place by various governments resulted in disruptions in the distribution of pumps and consumables.

Insulin Pump Market Segmentation

By application, the market includes type I diabetes and type II diabetes. By type, the market includes traditional, smart, and disposable insulin pumps.

By accessories, the market of insulin pumps includes insulin reservoirs, infusion sets, and infusion set insertion devices.

By end user, the market includes hospitals and clinics, home care, and laboratories.

Buy Now: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=1637

Insulin Pumps Market Regional Insights

Due to the introduction of good reimbursement practices for insulin pumps in the U.S., the region dictated this industry. Medical device manufacturers operating in the area will also aid the market's expansion. The rising incidence of diabetes will primarily fuel the market in Europe. The scenario is bound to increase demand for these pumps, along with additional management of diabetes tools. As more people attempt to change their lifestyles, the Asia-Pacific market will likely see rapid growth due to the expanding rates of chronic diseases like diabetes. The increasing number of elderly people and urbanization, which has caused a sedentary lifestyle to be adopted in the area, are two additional factors contributing to the rise in type 2 diabetes cases worldwide.

Discover more research Reports on Healthcare Industry by Market Research Future:

Infusion Pump Market Research Report Information By Type (Volumetric Pump and Syringe Pump), By Application (Chemotherapy, Diabetes, Gastrointestinal Diseases, and Pediatrics), By End Users (Hospitals, Ambulatory Surgical Centers, and Homecare), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2027

Insulin Delivery Devices (Idd) Market Size, Application And Trends Analysis By Type (Insulin Syringes, Pen, Insulin Pumps, Insulin Jet Injectors, Pen Needles And Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales And Diabetes Clinics/ Centers), By End User (Hospitals & Clinics, Homecare And Specialty Centres) - Forecast till 2030

Blood glucose monitoring market Research Report: Information by Product (Self-monitoring Blood Glucose Devices, Continuous Blood Glucose Monitoring Devices), By Application (Type 1 Diabetes, Type 2 Diabetes), By End Users (Hospitals & Clinics, Diagnostic Centers, Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Forecast Till 2030.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter

 

Contact Data